Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

The role of TMEM106B in Alzheimer’s disease pathophysiology

Project Overview

Alzheimer’s disease is a common form of memory loss and confusion affecting older adults. Despite many years of study, we still don’t have a cure for this disease. Researchers have found that certain genes might play a role, but we are still trying to understand how these genes actually cause Alzheimer’s. One such gene, called TMEM106B,has caught our attention because of its unique properties.
Our study aims to understand how changes in the TMEM106B gene contribute to Alzheimer’s disease. Specifically,we want to find out if altering this gene’s activity can affect the buildup of harmful substances in the brain, which is a hallmark of Alzheimer’s.
We will use special lab-grown brain cells, derived from human stem cells, to study the TMEM106B gene. By using advanced techniques, we can either increase or decrease the activity of this gene and observe the effects on the brain cells. This approach is different from previous studies because it allows us to directly manipulate the gene in a controlled setting, offering more precise insights.
Understanding how the TMEM106B gene works could lead to new ways of treating or even preventing Alzheimer’s disease. If we find that adjusting this gene’s activity can lessen harmful substances in the brain, we could be one step closer to developing effective treatments for Alzheimer’s.
Our research is particularly important for people who are living with Alzheimer’s or are at risk of developing it. By studying this gene, we are digging deeper into the root causes of Alzheimer’s, which could eventually help us to find new treatments that can improve the quality of life for those affected by this devastating disease.

Principal Investigator

Anthony Flamier , Université de Montréal

Partners and Donors

Alzheimer Society of Canada

Project Ongoing

The role of TMEM106B in Alzheimer’s disease pathophysiology

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Alzheimer Society Research Program (ASRP)

  • Province

    Québec

  • Start Date

    2024

  • Total Grant Amount

    $100,000

  • Health Canada Contribution

    $50,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co

  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds
Project Directory
Donate Now